UNIGE document Scientific Article
previous document  unige:154827  next document
add to browser collection

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

Kim, Rathana
Boissel, Nicolas
Touzart, Aurore
Leguay, Thibaut
Thonier, Florian
Thomas, Xavier
Raffoux, Emmanuel
show hidden authors show all authors [1 - 27]
Published in Leukemia. 2020, vol. 34, no. 7, p. 1730-1740
Abstract The prognostic value of IL7-receptor pathway (IL7Rp) mutations in T-cell acute lymphoblastic leukemia (T-ALL) remains unclear. We performed a comprehensive study of 200 adult patients with T-ALL included in the GRAALL2003/2005 protocols to address the clinical significance of IL7Rp mutations. Next-generation sequencing of the IL7Rp (IL7R/JAK1/JAK3/STAT5B) revealed that IL7Rp mutations were frequent in adult T-ALL (28%) particularly in immature/early T-cell progenitor (ETP)-ALL. They were associated with mutations of NOTCH-pathway, PHF6, and PRC2 components but not with K/NRAS. IL7Rp mutated (IL7Rpmut) T-ALL were slow-responders, with a high rate of M2/M3 day-8 marrow compared with IL7Rp non-mutated (IL7RpWT) T-ALL (p = 0.002) and minimal residual disease positivity at 6-weeks (MRD1) (p = 0.008) but no difference in MRD2 positivity at 12-weeks. Despite this, no adverse prognosis was evidenced when censored for allogeneic hematopoietic stem cell transplantation (HSCT). In time-dependent analysis, HSCT did not benefit IL7Rpmut patients whereas it was of marked benefit to IL7RpWT cases. IL7Rp-mutations identify a subgroup of slow-responder T-ALLs which benefit from post-induction chemotherapy regimens but not from HSCT. Our data suggest that prior knowledge of the mutation status of IL7Rp may influence HSCT decision and help to guide therapy reduction.
Keywords AdolescentAdultBiomarkersTumor/geneticsFemaleFollow-Up StudiesGene Expression RegulationNeoplasticHematopoietic Stem Cell Transplantation/mortalityHumansMaleMiddle AgedMutationNeoplasmResidual/genetics/pathology/therapyPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics/pathology/therapyPrognosisReceptorsInterleukin-7/geneticsSurvival RateTransplantationHomologousYoung Adult
PMID: 31992840
Full text
Article (Published version) (1.4 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982)
(ISO format)
KIM, Rathana et al. Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation. In: Leukemia, 2020, vol. 34, n° 7, p. 1730-1740. doi: 10.1038/s41375-019-0685-4 https://archive-ouverte.unige.ch/unige:154827

67 hits

0 download


Deposited on : 2021-09-20

Export document
Format :
Citation style :